Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New paper published in Nature Communications from researchers in Respiratory Medicine Unit, NDM Experimental Medicine'

Mucosal-associated invariant T (MAIT) cells are a recently-discovered type of white blood cell which are believed to play an important role in protecting humans, and many other mammals, from infections. They are able to detect minute quantities of vitamin metabolites produced in cells infected with bacteria and yeasts, but so far they have not been shown to protect against a major human disease. In work undertaken at the University of Melbourne, and published in the journal Nature Communications, the team and I have shown that in humans and animals MAIT cells can respond to two strains of Legionella: the bacterium which causes the very serious lung infection, Legionnaire’s disease. Importantly we showed in mice that having MAIT cells improves the chances of survival. For the first time we also showed that this protection against disease could be improved by activating these cells with vitamin metabolites. This could be an exciting new approach to protecting people against serious lung infections.

Find out more (Nature Communications)